A new report predicts the global needle-free delivery devices market to be worth almost 5.9 billion dollars by 2022. The market generated sales of 950.0 million dollars in 2010 according to Needle-Free Delivery: Technology and Market, 2012-2022, published in January 2012.
Needle-free injection technology is a mix of old and new technologies. Jet injectors are a well established segment of the market and will see increased growth over the forecast period. The second segment of the market is the competing technologies market. This segment includes innovative technologies such as microneedle patches.
James Sheppard, healthcare industry analyst says ‘The needle-free delivery market has seen slow growth in recent years and is only now beginning to expand. Growth will be driven by new technologies such as microneedle patches and novel jet injectors. Over the course of the next decade there will be greater demand for needle-free delivery devices as the technology becomes more attractive to big pharmaceutical companies.’
The research suggests that the needle-free delivery market will benefit from reducing prices, increasing efficiency in manufacturing processes and growth of emerging economies. Increasing healthcare awareness in emerging economies will mean more vaccine programs, which will help to drive the market. Mature markets such as the US and Japan will also experience double digit growth.
Needle-free delivery devices will have significant opportunities for growth during the forecast period. An analysis of jet injectors and the competing technologies pipelines showed a great deal of promise in the future. Leading experts in the field that are interviewed, have stated that there is significant opportunity for growth over the coming years. The products currently in development will offer significant opportunities, aided by advances in nanotechnology.